Asset Management One Co. Ltd. Has $15.06 Million Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Asset Management One Co. Ltd. grew its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 7.0% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 186,554 shares of the company's stock after buying an additional 12,142 shares during the period. Asset Management One Co. Ltd.'s holdings in GE HealthCare Technologies were worth $15,057,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in GEHC. Haverford Trust Co lifted its position in GE HealthCare Technologies by 2.4% in the 4th quarter. Haverford Trust Co now owns 4,896 shares of the company's stock valued at $383,000 after acquiring an additional 115 shares in the last quarter. Intact Investment Management Inc. lifted its position in GE HealthCare Technologies by 15.4% in the 4th quarter. Intact Investment Management Inc. now owns 900 shares of the company's stock valued at $70,000 after acquiring an additional 120 shares in the last quarter. LGT Financial Advisors LLC lifted its position in GE HealthCare Technologies by 46.2% in the 4th quarter. LGT Financial Advisors LLC now owns 389 shares of the company's stock valued at $30,000 after acquiring an additional 123 shares in the last quarter. Integrated Wealth Concepts LLC lifted its position in GE HealthCare Technologies by 0.7% in the 4th quarter. Integrated Wealth Concepts LLC now owns 17,173 shares of the company's stock valued at $1,343,000 after acquiring an additional 126 shares in the last quarter. Finally, Parallel Advisors LLC lifted its position in GE HealthCare Technologies by 1.9% in the 4th quarter. Parallel Advisors LLC now owns 7,135 shares of the company's stock valued at $558,000 after acquiring an additional 135 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company's stock.

Analyst Ratings Changes

Several equities research analysts recently commented on GEHC shares. UBS Group raised shares of GE HealthCare Technologies from a "sell" rating to a "neutral" rating and cut their price objective for the company from $74.00 to $73.00 in a research report on Monday, May 5th. Wells Fargo & Company cut their price target on shares of GE HealthCare Technologies from $103.00 to $89.00 and set an "overweight" rating on the stock in a research report on Thursday, May 1st. The Goldman Sachs Group cut their price target on shares of GE HealthCare Technologies from $94.00 to $82.00 and set a "buy" rating on the stock in a research report on Thursday, May 1st. BTIG Research set a $95.00 price target on shares of GE HealthCare Technologies and gave the stock a "buy" rating in a research report on Monday, April 14th. Finally, Morgan Stanley cut their price target on shares of GE HealthCare Technologies from $86.00 to $78.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th. Three investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $88.27.

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock traded down $0.48 during trading on Friday, hitting $74.38. 6,672,640 shares of the stock were exchanged, compared to its average volume of 3,533,418. The stock has a market capitalization of $34.06 billion, a price-to-earnings ratio of 15.66, a price-to-earnings-growth ratio of 2.45 and a beta of 1.13. The company has a fifty day moving average price of $70.36 and a 200-day moving average price of $77.70. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $94.80. The company has a current ratio of 0.98, a quick ratio of 0.76 and a debt-to-equity ratio of 0.73.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings data on Wednesday, April 30th. The company reported $1.01 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.10. The company had revenue of $4.78 billion for the quarter, compared to analyst estimates of $4.66 billion. GE HealthCare Technologies had a net margin of 11.02% and a return on equity of 24.95%. GE HealthCare Technologies's revenue for the quarter was up 2.7% compared to the same quarter last year. During the same period in the previous year, the business earned $0.90 EPS. As a group, equities analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies declared that its board has authorized a stock repurchase program on Wednesday, April 30th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the company to purchase up to 3.1% of its stock through open market purchases. Stock buyback programs are often a sign that the company's board of directors believes its shares are undervalued.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.